Pregnancy and fetal outcomes following maternal exposure to glatiramer acetate in three trimesters of pregnancy

被引:0
|
作者
Kaplan, Sigal [1 ]
Zeygarnik, Mikhail [1 ]
Stern, Tali [1 ]
Hellwig, Kerstin [2 ]
机构
[1] Teva Pharmaceut Ind Ltd, Tel Aviv, Israel
[2] Katholisches Klinikum Bochum gGmbH, Bochum, Germany
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
1118
引用
收藏
页码:526 / 526
页数:1
相关论文
共 50 条
  • [1] Pregnancy and fetal outcomes following maternal exposure to glatiramer acetate in all three trimesters of pregnancy
    Kaplan, Sigal
    Zeygarnik, Mikhail
    Stern, Tal
    Hellwig, Kerstin
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 (12) : 3890 - 3895
  • [2] Pregnancy and fetal outcomes following maternal exposure to glatiramer acetate
    Kaplan, Sigal
    Zeygarnik, Mikhail
    Stern, Tali
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 305 - 306
  • [3] Pregnancy, Fetal, and Infant Outcomes Following Maternal Exposure to Glatiramer Acetate During Pregnancy and Breastfeeding
    Kaplan, Sigal
    Zeygarnik, Mikhail
    Stern, Tal
    DRUG SAFETY, 2022, 45 (04) : 345 - 357
  • [4] Pregnancy, Fetal, and Infant Outcomes Following Maternal Exposure to Glatiramer Acetate During Pregnancy and Breastfeeding
    Sigal Kaplan
    Mikhail Zeygarnik
    Tal Stern
    Drug Safety, 2022, 45 : 345 - 357
  • [5] Pregnancy and fetal outcomes following paternal exposure to glatiramer acetate
    Kaplan, Sigal
    Dragut, Claudia Florentina
    Ghimpeteanu, Andra
    CURRENT MEDICAL RESEARCH AND OPINION, 2024, 40 (05) : 821 - 825
  • [6] Pregnancy and fetal outcomes following paternal exposure to glatiramer acetate
    Kaplan, Sigal
    Dragut, Claudia
    Ghimpeteanu, Andra
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 525 - 525
  • [7] Pregnancy and foetal outcomes and breastfeeding practices following maternal exposure to glatiramer acetate
    Kaplan, S.
    Zeygarnik, M.
    Stern, T.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 248 - 249
  • [8] Pregnancy and Fetal Outcomes after Maternal Exposure to Glatiramer Acetate-An Updated Analysis
    Kaplan, Sigal
    Dragut, Claudia
    Ghimpeteanu, Andra
    Neagu, Diana
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 665 - 665
  • [9] Pregnancy outcomes in patients with multiple sclerosis and exposure to branded glatiramer acetate during all three trimesters
    Hellwig, Kerstin
    Neudorfer, Orit
    Melamed-Gal, Sigal
    Baruch, Peleg
    Qassem, Shahd
    NEUROLOGY, 2018, 90
  • [10] Pregnancy outcomes in patients with multiple sclerosis and exposure to branded glatiramer acetate during all three trimesters
    Hellwig, K.
    Neudorfer, O.
    Melamed-Gal, S.
    Baruch, P.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 384 - 384